Whitehawk Therapeutics (WHWK) Capital Expenditures (2016 - 2025)
Whitehawk Therapeutics (WHWK) reported Capital Expenditures of $552000.0 for Q4 2025, up 275.24% year-over-year from $147106.6 in Q4 2024, and up 200.18% quarter-over-quarter from -$551000.0 in Q2 2025.
Whitehawk Therapeutics (WHWK) Capital Expenditures (2016 - 2025) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 9 years of Capital Expenditures data on file, last reported at $552000.0 in Q4 2025.
- Capital Expenditures for Q4 2025 came in at $552000.0, up 275.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $1000.0 (down 99.9% YoY), and the FY2025 annual result was $552000.0, down 52.12% from the prior year.
- Capital Expenditures climbed to $552000.0 in Q4 2025 per WHWK's latest filing, from -$551000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $3.8 million in Q4 2023 and troughed at -$1.9 million in Q3 2023.
- A 4-year average of $408066.7 and a median of $315000.0 in 2022 frame the typical range for Capital Expenditures.
- On a YoY basis, Capital Expenditures climbed as much as 5867.86% in 2023 and fell as far as 714.6% in 2023.
- A 4-year view of Capital Expenditures shows it stood at $78000.0 in 2022, then jumped by 4835.9% to $3.8 million in 2023, then plunged by 108.18% to -$315000.0 in 2024, then surged by 275.24% to $552000.0 in 2025.
- Business Quant data shows WHWK's Capital Expenditures at $552000.0 in Q4 2025, -$551000.0 in Q2 2025, and $551000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Whitehawk Therapeutics | 310.18 Mn | 187.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 552,000.00 |
| Dec 31, 2025 | 552,000.00 |
| Jun 30, 2025 | -551,000.00 |
| Jun 30, 2025 | -551,000.00 |
| Mar 31, 2025 | 551,000.00 |
| Mar 31, 2025 | 551,000.00 |
| Dec 31, 2024 | -315,000.00 |
| Dec 31, 2024 | -315,000.00 |
| Sep 30, 2024 | 877,000.00 |
| Sep 30, 2024 | 877,000.00 |
| Jun 30, 2024 | -148,000.00 |
| Jun 30, 2024 | -148,000.00 |
| Mar 31, 2024 | 739,000.00 |
| Mar 31, 2024 | 739,000.00 |
| Dec 31, 2023 | 3.85 Mn |
| Dec 31, 2023 | 3.85 Mn |
| Sep 30, 2023 | -1.94 Mn |
| Sep 30, 2023 | -1.94 Mn |
| Jun 30, 2023 | 1.67 Mn |
| Jun 30, 2023 | 1.67 Mn |